- Report
- October 2023
- 191 Pages
Global
From €3418EUR$3,554USD£2,934GBP
€3797EUR$3,949USD£3,260GBP
- Report
- October 2023
- 173 Pages
Global
From €4712EUR$4,900USD£4,045GBP
- Report
- October 2023
- 145 Pages
Global
From €3029EUR$3,150USD£2,600GBP
- Report
- January 2023
- 1469 Pages
Global
From €4808EUR$5,000USD£4,128GBP
- Report
- October 2023
- 199 Pages
Global
From €3418EUR$3,554USD£2,934GBP
€3797EUR$3,949USD£3,260GBP
- Report
- September 2023
- 175 Pages
Global
From €3846EUR$4,000USD£3,302GBP
€4808EUR$5,000USD£4,128GBP
- Report
- September 2023
- 175 Pages
Global
From €3846EUR$4,000USD£3,302GBP
€4808EUR$5,000USD£4,128GBP
- Report
- February 2023
- 250 Pages
Global
From €3846EUR$4,000USD£3,302GBP
€4808EUR$5,000USD£4,128GBP
- Report
- October 2023
- 150 Pages
Global
From €4664EUR$4,850USD£4,004GBP
- Report
- December 2023
- 192 Pages
Global
From €4760EUR$4,950USD£4,086GBP
- Report
- December 2023
- 193 Pages
Global
From €4760EUR$4,950USD£4,086GBP
- Report
- November 2023
- 175 Pages
Global
From €4808EUR$5,000USD£4,128GBP
- Report
- April 2023
- 115 Pages
Global
From €3883EUR$4,038USD£3,333GBP
€4568EUR$4,750USD£3,921GBP
- Report
- November 2023
- 30 Pages
Global
From €2500EUR$2,600USD£2,146GBP
€3125EUR$3,250USD£2,683GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2116EUR$2,200USD£1,816GBP
€2644EUR$2,750USD£2,270GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2500EUR$2,600USD£2,146GBP
€3125EUR$3,250USD£2,683GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2116EUR$2,200USD£1,816GBP
€2644EUR$2,750USD£2,270GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2116EUR$2,200USD£1,816GBP
€2644EUR$2,750USD£2,270GBP
- Report
- September 2023
- 146 Pages
Global
From €3392EUR$3,528USD£2,912GBP
€3991EUR$4,150USD£3,426GBP
- Report
- April 2023
- 147 Pages
Global
From €5769EUR$5,999USD£4,952GBP

The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms.
The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more